AgentForce AI Revolutionizes Life Sciences Engagement in India
Discover how AgentForce's AI-powered platform is reshaping customer engagement in India's life sciences sector, eliminating burnout while boosting productivity by 40%.
Category : Search result: pharmaceutical company profit
Baddi Pharma Raid: Sub-Standard Medicines Shipped to Rajasthan
Himachal Pradesh drug control authorities raid Baddi pharmaceutical facility after Rajasthan complaints reveal distribution of sub-standard medicines across seven districts, raising serious public health concerns.
Bharat Biotech enters cell & gene therapy with Nucelion
Indian vaccine maker Bharat Biotech expands into high-growth CRDMO space with new subsidiary Nucelion Therapeutics, focusing on cutting-edge cell and gene therapies for cancer and rare diseases.
GHV Infra Q2: Revenue up 128%, Profit jumps 138%
GHV Infra Projects delivers explosive Q2 performance with revenue skyrocketing 128% and profits surging 138%, signaling strong growth momentum in India's infrastructure sector.
Sigma Solve Q2 Profit Jumps 54% to ₹1.93 Crore
Sigma Solve Limited reports impressive Q2 FY25 results with 54% YoY profit surge, revenue growth of 26.65%, and expanding EBITDA margins. The tech solutions provider demonstrates strong financial performance.
Indian Exports to US Crash 37.5% Amid Trump Tariffs
Indian exports to the US plummeted 37.5% amid 50% Trump tariffs, with smartphones and pharmaceuticals taking the biggest hit. Get the complete trade impact analysis.
US Tariffs Crush Indian Exports: 37.5% Plunge
GTRI report reveals devastating 37.5% decline in India's key exports to US, with smartphones, pharmaceuticals, and gems taking the hardest hit from American tariff policies.
Vedanta Q2 Profit Plunges 59% Amid Write-Off
Vedanta Ltd reports steep 59% drop in Q2 net profit to ₹1,308 crore amid one-time power business write-off. Analysts question demerger delays and JP Morgan's bid as company navigates debt challenges.
FDA Recalls Blood Pressure Meds Over Cancer Risk
Multiple blood pressure medications recalled after FDA detects potential cancer-causing impurities. Find out if your medication is affected and what steps to take immediately.
Health Biotech Expands Global Presence at CPhI Frankfurt
Indian biopharmaceutical leader Health Biotech Limited makes waves at CPhI Frankfurt 2025, showcasing innovative products and forging international partnerships to strengthen its global market position.
Niner Pharma Expands R&D with 125 New Peptide Molecules
Chandigarh-based Niner Pharma announces massive R&D expansion with 125 novel peptide molecules targeting wellness and cosmetic innovation, positioning India as global leader in peptide research.
GAIL Q2 Profit Beats Estimates, Revenue Grows
India's largest natural gas company GAIL delivers impressive Q2 FY26 performance with net profit beating street estimates and revenue growing marginally despite challenging market conditions.
Apple iPhone Drives Record Sales and Profit Surge
Apple's iPhone drives unprecedented revenue growth with record-breaking sales, defying global smartphone market trends and setting new benchmarks for profitability.
Cipla CEO Change: Achin Gupta Succeeds Umang Vohra
Indian pharmaceutical giant Cipla reveals strategic leadership transition with Achin Gupta succeeding Umang Vohra as Global CEO in September 2024, marking a new era for the company.
FDA Recalls 580K Blood Pressure Meds Over Cancer Risk
Major pharmaceutical recall alert: FDA discovers carcinogenic impurity in popular blood pressure medications, affecting hundreds of thousands of patients across the US. Safety concerns prompt immediate withdrawal.
Eli Lilly Ups Forecast as Zepbound Demand Soars
Pharmaceutical giant Eli Lilly raises full-year profit forecast as demand skyrockets for revolutionary weight-loss treatment Zepbound, sending shares climbing 7%.
Sharda Cropchem Q2 Profit Jumps 75%, Revenue Up 20%
Agrochemical major Sharda Cropchem delivers stellar Q2 performance with massive profit growth and strong revenue increase, showcasing robust demand in global markets.
Cipla Shares Fall 4% After Q2 Results
Cipla's stock faced significant pressure after Q2 FY2025 results revealed margin pressures despite revenue growth. Discover the key factors behind the 4% decline and what analysts are saying about the pharmaceutical giant's future prospects.
Punjab de-addiction centres sold pills in black market: ED probe
Shocking probe reveals Punjab doctor's de-addiction centres allegedly operated pill trafficking network while claiming to treat addiction. ED uncovers massive pharmaceutical diversion scheme.
Cognizant Exploring India IPO Listing
Cognizant Technology Solutions is actively exploring an initial public offering (IPO) in India, marking a significant strategic move that could reshape its relationship with the massive Indian market where it employs over 250,000 professionals.
India Bans Fraudulent Pharma Licenses in Major Reform
India implements sweeping regulatory reforms to combat fraudulent pharmaceutical manufacturing licenses, enhancing drug safety standards for domestic and international markets including US and EU.
Sinopec Profits Drop 33% on Oil Slump, Weak Fuel Sales
China Petroleum & Chemical Corporation (Sinopec) reports staggering 33% profit drop in first nine months of 2023 as lower crude prices and sluggish fuel sales impact earnings. Detailed analysis inside.
Eli Lilly & NVIDIA Partner for AI Drug Discovery
Pharmaceutical giant Eli Lilly partners with NVIDIA to deploy cutting-edge AI supercomputers that will accelerate drug development and transform pharmaceutical research.
Texas Sues Johnson & Johnson Over Tylenol-Autism Link
The state of Texas has filed a lawsuit against Johnson & Johnson and its spin-off Kenvue, alleging the companies failed to warn consumers about potential autism risks associated with Tylenol use during pregnancy. This legal action comes just weeks after f
Newgen Software Q2: Revenue up 11%, Profit jumps 16%
Newgen Software Technologies reports impressive Q2 FY2024 results with 11% revenue growth and 16% profit surge, driven by robust demand for digital transformation solutions.
TTK Prestige Q2 Profit Soars 22% to ₹63.20 Cr
TTK Prestige delivers stellar Q2 performance with robust profit growth and strong revenue increase, showcasing exceptional demand for kitchen appliances across India.
Sundaram Home Finance Q2 Profit Hits ₹75 Crore
Sundaram Home Finance reports impressive ₹75 crore net profit in Q2 FY2024, showcasing strong growth in disbursements and assets under management despite market challenges.
Sanofi India appoints Deepak Arora as Managing Director
Sanofi India announces Deepak Arora as its new Managing Director, bringing extensive pharmaceutical experience to drive growth and innovation in the Indian healthcare market.
India probes anti-dumping of TB drugs from China, Thailand
India initiates anti-dumping investigation on tuberculosis medication imports from China and Thailand following domestic industry complaints about unfair pricing practices affecting local manufacturers.
SafeCure Services IPO: ₹60 Cr Offer Opens Oct 29
Delhi-based pharmaceutical support company SafeCure Services Ltd plans to raise up to ₹60 crore through IPO. Fresh issue of 48 lakh shares priced at ₹60-75 each. Learn key dates and details.
Page 3 of 4